Clinical course, safety of low-dose rituximab for vietnameses patients with neuromyelitis optica spectrum disorder

被引：0
|
作者：
Le, T. [1 ]
机构：
[1] Ha Noi Med Univ Hosp, Hanoi, Vietnam
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
LB1215
引用
收藏
页码：83 / 83
页数：1
相关论文
共 50 条
  • [1] Low-dose Rituximab therapy for neuromyelitis optica spectrum disorders
    Novo, A.
    Correia, I.
    Marques, I.
    Batista, S.
    Sousa, L.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 542 - 542
  • [2] Efficacy and safety of low- and ultralow-dose rituximab in neuromyelitis optica spectrum disorder
    Zhang, Chengyi
    Liu, Rui
    Gao, Bin
    Li, Ting
    Wang, Huabing
    Song, Tian
    Ma, Yuetao
    Xu, Wangshu
    Liu, Yun
    Zhang, Xinghu
    Tian, De-Cai
    Yang, Chunsheng
    Shi, Kaibin
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2024, 387
  • [3] Low-dose tacrolimus in treating neuromyelitis optica spectrum disorder
    Wang, Liang
    Tan, Hongmei
    Huang, Wenjuan
    ZhangBao, Jingzi
    Chang, Xuechun
    Zhou, Lei
    Lu, Chuanzhen
    Wang, Min
    Lu, Jiahong
    Zhao, Chongbo
    Quan, Chao
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 48
  • [4] Safety and efficacy of rituximab in neuromyelitis optica spectrum disorder
    Radaelli, M.
    Moiola, L.
    Privitera, D.
    Rodegher, M.
    Colombo, B.
    Barcella, V.
    Sangalli, F.
    Esposito, F.
    Comi, G.
    Martinelli, V.
    [J]. JOURNAL OF NEUROLOGY, 2011, 258 : 261 - 262
  • [5] Low-dosage of rituximab in Chinese patients with neuromyelitis optica spectrum disorder
    Lin, Jie
    Li, Xiang
    Xue, Binbin
    Tong, Qiuling
    Chen, Zhibo
    Zhu, Weiqian
    Li, Jia
    Xia, Junhui
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2018, 317 : 1 - 4
  • [6] Efficacy and safety of azathioprine, mycophenolate mofetil, and reduced dose of rituximab in neuromyelitis optica spectrum disorder
    Huang, Wenjuan
    Wang, Liang
    Xia, Junhui
    Li, Wenyu
    Wang, Min
    Yu, Jian
    Li, Qinying
    Wang, Bei
    Pan, Juyuan
    Du, Lei
    Ma, Jianhua
    Tan, Hongmei
    Chang, Xuechun
    Lu, Chuanzhen
    Zhao, Chongbo
    Lu, Jiahong
    Zhou, Lei
    ZhangBao, Jingzi
    Quan, Chao
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (08) : 2343 - 2354
  • [7] Efficacy and safety of rituximab in multiple sclerosis and neuromyelitis optica spectrum disorder
    Tatchaporn Ongphichetmetha
    Jiraporn Jitprapaikulsan
    Sasitorn Siritho
    Natthapon Rattanathamsakul
    Thammachet Detweeratham
    Naraporn Prayoonwiwat
    [J]. Scientific Reports, 14
  • [8] Efficacy and safety of rituximab in multiple sclerosis and neuromyelitis optica spectrum disorder
    Ongphichetmetha, Tatchaporn
    Jitprapaikulsan, Jiraporn
    Siritho, Sasitorn
    Rattanathamsakul, Natthapon
    Detweeratham, Thammachet
    Prayoonwiwat, Naraporn
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01)
  • [9] Rituximab treatment in patients affected by neuromyelitis optica spectrum of disorder: long term safety and efficacy in clinical practice
    Radaelli, M.
    Moiola, L.
    Rodegher, M.
    Colombo, B.
    Barcella, V.
    Sangalli, F.
    Ferre, L.
    Fazio, R.
    Esposito, F.
    Martinelli, V.
    Comi, G.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 88 - 88
  • [10] Clinical course of neuromyelitis optica spectrum disorder in a moroccan cohort
    Bennis, Anas
    El Otmani, Hicham
    Benkirane, Nada
    Harrizi, Ilham
    El Moutawakil, Bouchra
    Abdoh Rafai, Mohammed
    Slassi, Ilham
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 30 : 141 - 148
12345